MRM
HZNP

Michael R. Murphy’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Michael R. Murphy’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,187,854
Closed -$28.2M – 26
2014
Q4 		$28.2M Sell
2,187,854
-209,766
-9% -$2.63M 10.84% 2
2014
Q3 		$29.4M Sell
2,397,620
-20,234
-0.8% -$235K 10.19% 1
2014
Q2 		$38.3M Sell
2,417,854
-29,393
-1% -$420K 12.16% 1
2014
Q1 		$37M Sell
2,447,247
-3,729,129
-60% -$42.1M 10.96% 1
2013
Q4 		$47.1M Sell
6,176,376
-67,870
-1% -$366K 17.8% 1
2013
Q3 		$20.9M Buy
6,244,246
+87,369
+1% +$230K 8.67% 2
2013
Q2 		$15.1M Buy
+6,156,877
New +$14.8M 6.93% 7

Other funds holding HZNP

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Michael R. Murphy's HZNP Position: Q1 2015 in Review

Michael R. Murphy sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2015, closing a stake of 2,187,854 shares — an estimated $28.2M sold.

Michael R. Murphy first reported a position in HZNP in Q2 2013 and held it in 7 quarters. The position peaked at $47.1M in Q4 2013. 177 funds tracked by Wall St. Rank hold HZNP as of Q1 2015.

  • Michael R. Murphy reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2015 after selling out during the quarter.
  • Michael R. Murphy sold 2,187,854 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2015, an estimated $28.2M.
  • Michael R. Murphy first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2013 and held it in 7 quarters.
  • Michael R. Murphy's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $47.1M in Q4 2013.
  • 177 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2015.

Based on Michael R. Murphy's 13F filing for Q1 2015, filed 14 May 2015.